Phase II clinical trials of mature B-cell neoplasms in children: A Japanese Cooperative Studies
Phase 2
- Conditions
- mature B-cell non-Hodgkin's lymphoa
- Registration Number
- JPRN-C000000317
- Lead Sponsor
- Japanese Pediatric Leukemia/Lymphoma Studu Group(JPLSG)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 308
Inclusion Criteria
Not provided
Exclusion Criteria
1, Down's syndrome(21 trisomy) 2, Previous malignancy of any type 3, Prior stem cell/organ transplantation 4, Congenital immunodeficiency 5, HIV positivity
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 2 year event-free survival
- Secondary Outcome Measures
Name Time Method (1) 2 year overall survival (2) incidence of therapy-related severe toxicity